Document is current
Any future updates will be listed below
-
Authors
Alnagar, Ahmed Nashaat https://orcid.org/0000-0001-7773-5230
Motawea, Amira https://orcid.org/0000-0001-6223-6332
Zaghloul, Randa A. https://orcid.org/0000-0001-7827-195X
Eldesoqui, Mamdouh https://orcid.org/0000-0002-6589-4514
Abu Hashim, Irhan Ibrahim
-
Funding
Funding for this research was provided by:
Mansoura University
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 5 December 2024
First Online: 16 January 2025
Declarations
:
: The study protocol was designed to meet the terms of the ARRIVE guidelines for the care and use of animals for scientific purposes and approved by the Research Ethics Committee, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt, Code No. 2024-08, following “Principles of Laboratory Animal Care” (National Institute of Health Publication No. 85–23, updated 1985).
: Not applicable because no human studies were carried out by the authors for this article.
: We submit the manuscript entitled: A novel facile and efficient prophylaxis avenue of chitosan oligosaccharide/PLGA based polydatin loaded nanoparticles against bleomycin-induced lung inflammation in experimental rat model. All authors agreed with the final version of this manuscript and with the current submission for publication in “AAPS PharmSciTech”.
